Año 2019 / Volumen 111 / Número 11
Original
Prognostic value of serum high-density lipoprotein cholesterol in patients with gallbladder cancer

839-845

DOI: 10.17235/reed.2019.6201/2019

Bo Yuan, Jing Fu, Wen-Long Yu, Xiao-Hui Fu, Ying-He Qiu, Lei Yin, Bin Zhu, Yong-Jie Zhang,

Resumen
Objectives: the aim of this study was to evaluate the prognostic significance of preoperative serum lipid in patients with gallbladder cancer (GBC). Methods: ninety-nine patients with GBC between October 2009 and December 2013 were reviewed in this retrospective study. Total serum cholesterol (TC), total triglyceride (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), apolipoprotein A (Apo-A), apolipoprotein B (Apo-B) and free fatty acids (FFA) were measured before surgery. The correlation of serum lipid levels with clinical data, including gender, age, tumor size, lymph nodes metastasis, tumor differentiation, distant metastasis and TNM stage were analyzed by univariate and multivariate survival analysis to evaluate independent prognostic factors. Results: compared with the normal HDL-C group (n = 57), the overall survival rate among GBC patients with low HDL-C levels (n = 42) was reduced (p < 0.05). However, there were no significant differences in overall survival for patients with different levels of TC, TG, Apo-A, Apo-B, LDL-C or FFA. The serum level of HDL-C was associated with TNM stage (p < 0.05) and distant metastasis (p < 0.001). The multivariate prognosis analysis showed that HDL-C and lymph nodes metastasis were independent prognostic factors (p < 0.05). A prognostic evaluation model based on HDL-C and lymph nodes metastasis was established. Conclusion: preoperative serum HDL-C level was closely associated with distant metastasis of patients with GBC. HDL-C level may be a valuable prognostic factor for GBC patients. The combination of HDLC and lymph nodes metastasis can better predict the prognosis of GBC.
Share Button
Nuevo comentario
Comentarios
No hay comentarios para este artículo.
Bibliografía
1. Justo I, Marcacuzco A, Nutu OA, et al. A retrospective analysis of patients with gallbladder cancer: surgical treatment and survival according to tumor stage. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 2018;110(8):485-492. DOI: 10.17235/reed.2018.5435/2017
2. Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clinical epidemiology 2014;6:99-109. DOI:10.2147/CLEP.S37357
3. Tuo JY, Zhang M, Zheng RS, et al. [Report of incidence and mortality of gallbladder cancer in China, 2014]. Zhonghua zhong liu za zhi.2018;40(12):894-899.doi: 10.3760/cma.j.issn.0253-3766.2018.12.004
4. Are C, Ahmad H, Ravipati A, et al. Global epidemiological trends and variations in the burden of gallbladder cancer. Journal of surgical oncology 2017;115(5):580-590. DOI:10.1002/jso.24546
5. Kim SH, Jung D, Ahn JH, et al. Differentiation between gallbladder cancer with acute cholecystitis: Considerations for surgeons during emergency cholecystectomy, a cohort study. International journal of surgery 2017;45:1-7. DOI:10.1016/j.ijsu.2017.07.046
6. Lee JW, Kim YT, Lee SH, et al. Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy. Gut and liver 2018;12(1):102-110. DOI:10.5009/gnl16588
7. Muntoni S, Atzori L, Mereu R, et al. Serum lipoproteins and cancer. Nutrition, metabolism, and cardiovascular diseases : NMCD 2009;19(3):218-25. DOI:10.1016/j.numecd.2008.06.002
8. Yang Z, Qin W, Chen Y, et al. Cholesterol inhibits hepatocellular carcinoma invasion and metastasis by promoting CD44 localization in lipid rafts. Cancer letters 2018;429:66-77. DOI:10.1016/j.canlet.2018.04.038
9. Li X, Tang H, Wang J, et al. The effect of preoperative serum triglycerides and high-density lipoprotein-cholesterol levels on the prognosis of breast cancer. Breast 2017;32:1-6. DOI:10.1016/j.breast.2016.11.024
10. Mao M, Wang X, Sheng H, et al. A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients. BMC cancer 2018;18(1):1178. DOI:10.1186/s12885-018-5028-8
11. Nagao M, Nakajima H, Toh R, et al. Cardioprotective Effects of High-Density Lipoprotein Beyond its Anti-Atherogenic Action. Journal of atherosclerosis and thrombosis 2018;25(10):985-993. DOI:10.5551/jat.RV17025
12. Bergquist JR, Shah HN, Habermann EB, et al. Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study). International journal of surgery 2018;52:171-179. DOI:10.1016/j.ijsu.2018.02.052
13. Jiang SS, Weng DS, Jiang L, et al. The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma. Journal of Cancer 2016;7(6):626-32. DOI:10.7150/jca.13837
14. Liu YY, Lin SJ, Chen YY, et al. High-density lipoprotein cholesterol as a predictor of poor survival in patients with nasopharyngeal carcinoma. Oncotarget 2016;7(28):42978-42987. DOI:10.18632/oncotarget.7160
15. Fang BA, Kovacevic Z, Park KC, et al. Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy. Biochimica et biophysica acta 2014;1845(1):1-19. DOI:10.1016/j.bbcan.2013.11.002
16. Nishio S, Ushijima K, Tsuda N, et al. Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma. Cancer letters 2008;264(1):36-43. DOI:10.1016/j.canlet.2008.01.020
17. Kawahara A, Akiba J, Hattori S, et al. Nuclear expression of N-myc downstream regulated gene 1/Ca(2+)-associated protein 43 is closely correlated with tumor angiogenesis and poor survival in patients with gastric cancer. Experimental and therapeutic medicine 2011;2(3):471-479. DOI:10.3892/etm.2011.222
18. Zhang SB, Song SP, Li B, et al. Expression of N-myc downstream-regulated gene 1 in primary gallbladder carcinoma and its correlation with clinicopathological features and clinical outcome. Medical oncology 2012;29(3):1866-72. DOI:10.1007/s12032-011-0017-7
19. Hunter M, Angelicheva D, Tournev I, et al. NDRG1 interacts with APO A-I and A-II and is a functional candidate for the HDL-C QTL on 8q24. Biochemical and biophysical research communications 2005;332(4):982-92. DOI:10.1016/j.bbrc.2005.05.050
20. Pirro M, Ricciuti B, Rader DJ, et al. High density lipoprotein cholesterol and cancer: Marker or causative? Progress in lipid research 2018;71:54-69. DOI:10.1016/j.plipres.2018.06.001
21. Beloribi-Djefaflia S, Vasseur S, Guillaumond F. Lipid metabolic reprogramming in cancer cells. Oncogenesis 2016;5:e189. DOI:10.1038/oncsis.2015.49
Artículos relacionados

Original

Can we optimize CEA as a response marker in rectal cancer?

DOI: 10.17235/reed.2020.7321/2020

Editorial

El reto del colon derecho

DOI: 10.17235/reed.2018.5544/2018

Carta al Editor

Tumores neuroendocrinos de páncreas: claves para afrontar la heterogeneidad

DOI: 10.17235/reed.2017.4997/2017

Carta al Editor

Tumores neuroendocrinos de páncreas: factores pronósticos

DOI: 10.17235/reed.2017.5109/2017

Editorial

Tumores neuroendocrinos del páncreas: no tan raros y no tan benignos

DOI: 10.17235/reed.2016.4672/2016

Caso Clínico

Hemobilia por neoplasia papilar intracolecística

DOI: 10.17235/reed.2016.4205/2016

Instrucciones para citar
Yuan B, Fu J, Yu W, Fu X, Qiu Y, Yin L, et all. Prognostic value of serum high-density lipoprotein cholesterol in patients with gallbladder cancer. 6201/2019


Descargar en un gestor de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica
Este artículo ha sido visitado 1114 veces.
Este artículo ha sido descargado 135 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 30/01/2019

Aceptado: 26/04/2019

Prepublicado: 09/10/2019

Publicado: 07/11/2019

Tiempo de revisión del artículo: 80 días

Tiempo de prepublicación: 252 días

Tiempo de edición del artículo: 281 días


Compartir
Este artículo aun no tiene valoraciones.
Valoración del lector:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
La REED es el órgano oficial de la Sociedad Española de Patología Digestiva, la SociedadEspañola de Endoscopia Digestiva y la Asociación Española de Ecografía Digestiva
Política de cookies Política de Privacidad Aviso Legal © Copyright 2023 y Creative Commons. Revista Española de Enfermedades Digestivas